James Cheney
About James Cheney
James Cheney is the Sr. Director of Cell Therapy Facilities Quality at Bristol Myers Squibb, with extensive experience in cell therapy facilities quality management and a strong background in process validation and PAT.
Sr. Director, Cell Therapy Facilities Quality at Bristol Myers Squibb
James Cheney currently holds the position of Sr. Director, Cell Therapy Facilities Quality at Bristol Myers Squibb. He began this role on January 1, 2020, and brings extensive experience in managing quality for cell therapy facilities to the position. This role involves overseeing quality operations and ensuring regulatory compliance within the company’s cell therapy facilities. His expertise in quality management is pivotal for maintaining high standards in product quality and safety.
Head, Global Product Quality at Bristol-Myers Squibb
James Cheney also serves as the Head of Global Product Quality at Bristol-Myers Squibb in Summit, New Jersey. In this capacity, he is responsible for ensuring that products meet global quality standards and regulatory requirements. His responsibilities include oversight of quality systems, processes, and compliance for all products in the market. His experience and leadership in quality management are critical to maintaining the integrity and reputation of Bristol-Myers Squibb’s product portfolio.
Senior Director Roles at Celgene
At Celgene, James Cheney held multiple senior director roles focusing on different aspects of quality management. He served as the Senior Director of Global Product Quality and Senior Director of Process Validation & PAT (Process Analytical Technology). In these roles, he was responsible for overseeing the quality of global products and implementing process validation protocols to ensure consistent product quality. His work at Celgene contributed significantly to advancing the company’s quality assurance practices and regulatory compliance.
Executive Director at Novartis
James Cheney worked at Novartis for 29 years, from 1981 to 2010, culminating in his role as Executive Director. During his tenure, he gained extensive experience in various aspects of quality management and regulatory affairs. His long-standing commitment to the company and his expertise in the field added immense value to Novartis’s operational and quality standards. His time at Novartis laid a strong foundation for his subsequent roles in quality management in the pharmaceutical industry.
Expertise in Process Validation and PAT
James Cheney has a robust background in process validation and Process Analytical Technology (PAT). His expertise in these areas is reflected in his senior director role in Process Validation & PAT at Celgene, where he was responsible for developing and implementing validation protocols to ensure the quality and efficacy of manufacturing processes. His knowledge and experience in PAT have been instrumental in advancing the technological aspects of quality assurance in the pharmaceutical industry.